BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9269 related articles for article (PubMed ID: 2006449)

  • 1. Survival with regional and distant metastases from cutaneous malignant melanoma.
    Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
    Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile malignant melanoma.
    Reintgen DS; Vollmer R; Seigler HF
    Surg Gynecol Obstet; 1989 Mar; 168(3):249-53. PubMed ID: 2919354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck.
    Austin JR; Byers RM; Brown WD; Wolf P
    Head Neck; 1996; 18(2):107-17. PubMed ID: 8647675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasectomy in malignant melanoma.
    Karakousis CP; Velez A; Driscoll DL; Takita H
    Surgery; 1994 Mar; 115(3):295-302. PubMed ID: 8128354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of cutaneous malignant melanoma after more than 20 years.
    Bredgaard R; Lock-Andersen J
    J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
    Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
    Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.
    Amer MH; Al-Sarraf M; Vaitkevicius VK
    Surg Gynecol Obstet; 1979 Nov; 149(5):687-92. PubMed ID: 505243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality therapy for patients with regional nodal metastases from melanoma.
    Ballo MT; Ross MI; Cormier JN; Myers JN; Lee JE; Gershenwald JE; Hwu P; Zagars GK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):106-13. PubMed ID: 16182463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 464.